Search Results 281-290 of 24188 for B cell lymphomas

  1. A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies - Mayo Clinic

    Participation eligibility · Diagnosis of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) as documented by medical records and with histology based on ...

  2. Hematology - Clinical trials

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  3. Clinical trials - Oncology (Medical)

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  4. Publications - Allison C. Rosenthal, D.O. - Mayo Clinic

    Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell ...

  5. Oncology (Medical) - Doctors - Mayo Clinic

    Waldenstrom macroglobulinemia, Chronic lymphocytic leukemia, Lymphoma, Small lymphocytic lymphoma, B-cell lymphoma, Fol...licular lymphoma. Show more areas ...

  6. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    Chronic lymphocytic leukemia, Acute myelogenous leukemia, B-cell lymphoma, Burkitt lymphoma, T-cell lymphoma, Follicular lymphoma. Show more areas of focus ...

  7. CAR-T cell therapy - Doctors & Departments - Mayo Clinic

    ... B-cell lymphoma, Diffuse large b-cell lymphom...a, Acute myelogenous ... B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn ...

  8. Yi Lin, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    ... cell therapy. Conditions treated · Amyloidosis · B-cell lymphoma · Follicular lymphoma · Lymphoma · Multiple myeloma · T-cell lymphoma · Procedures performed.

  9. Understanding CAR-T cell therapy and its potential side effects

    Large B-cell lymphoma transformed from follicular lymphoma; High-grade B-cell lymphoma; Aggressive B-cell lymphoma not otherwise specified (NOS); Mantle ...

  10. Bispecific antibody therapy - Mayo Clinic

    Epcoritamab (Epkinly) and glofitamab (Columvi) also target CD3 and CD20 to treat diffuse large B-cell lymphoma (DLBCL) and related lymphomas. Solid tumors.